Carsten Struebing
4Patents
0h-index
7Co-inventors
27Inventor score
Filing activity: Oct 14, 2008 → Mar 12, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8030276B2 | Treating cardiovascular disease with TRPC3 channel protein | Physics | 0 | Active |
| US8455469B2 | Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels | Physics | 0 | Active |
| US9718825B2 | N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals | Chemistry; Metallurgy | 0 | Active |
| US8193150B2 | Improving vascular function with an inactivating mutant of a TRPC channel protein | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.